| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash Flows used in Operating Activities | |||||||||
Net loss and comprehensive loss | |||||||||
-26,294 | -17,252 | -13,460 | -14,736 | -12,108 | -9,968 | -3,700 | -8,301 | -7,307 | -8,783 |
Adjustments to reconcile net loss to net cash used in operations: | |||||||||
Amortization and depreciation | |||||||||
- | - | 0 | 1 | 0 | 0 | - | - | - | - |
Amortization and depreciation | |||||||||
- | - | - | - | - | - | 0 | 1 | 1 | 0 |
Accretion of debt discount | |||||||||
- | - | 0 | 5 | 4,515 | 1,917 | 0 | 98 | 69 | 1,836 |
Stock-based compensation | |||||||||
6,430 | 5,517 | 4,135 | 5,062 | 1,633 | 637 | 1,002 | 302 | 1,273 | 770 |
Deferred costs | |||||||||
151 | - | - | - | - | - | - | - | - | - |
Gain on settlement of accounts payable | |||||||||
115 | - | - | - | - | - | - | - | - | - |
Amortization of deferred financing charge | |||||||||
- | - | - | - | - | 1,123 | 1 | 62 | 44 | 55 |
Non-cash financing related charges | |||||||||
- | - | - | - | -29 | 0 | - | - | - | - |
Deferred income tax benefit | |||||||||
- | - | - | - | - | -1,400 | - | - | - | - |
Change in fair value of derivative financial instruments | |||||||||
- | - | - | - | -567 | 2,956 | - | - | - | - |
Non-cash financing related charges | |||||||||
- | - | - | - | -29 | - | - | - | - | - |
Change in fair value of derivative financial instruments | |||||||||
- | - | - | - | - | - | 15 | 67 | 100 | -630 |
Gain on extinguishment of debt | |||||||||
- | - | 0 | 61 | 84 | -8,539 | -495 | -3,829 | -198 | 0 |
Gain on settlement of accounts payable | |||||||||
- | - | 75 | 151 | 0 | 199 | - | - | - | - |
Unrealized foreign exchange | |||||||||
- | - | 0 | -3 | - | - | - | - | - | - |
Consulting expense recorded in exchange for shares to be issued | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Common shares issued for consulting expenses | |||||||||
- | - | - | - | - | - | 0 | 15 | 0 | 0 |
Promissory note issued for severance | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Common shares issued for severance | |||||||||
- | - | - | - | - | - | 0 | 75 | 0 | 0 |
Common shares issued for research and development expenses | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Management fees contributed | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Debt conversion expense | |||||||||
- | - | - | - | - | - | 0 | 0 | 504 | 0 |
Loss on settlement of accounts payable | |||||||||
- | - | - | - | - | - | -976 | 0 | -334 | -444 |
Rent contributed | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Unrealized foreign exchange | |||||||||
- | - | - | - | 18 | 18 | 4 | 0 | - | - |
Changes in non-cash working capital balances related to operations: | |||||||||
Sales tax recoverable | |||||||||
- | - | -54 | 2 | 76 | 0 | - | - | - | - |
Incentive and tax receivables | |||||||||
772 | 231 | - | - | - | - | 0 | -0 | -37 | 37 |
Prepaid expenses and deposits | |||||||||
-803 | 915 | 155 | 79 | 67 | 33 | 0 | -9 | -13 | 23 |
Accounts payable | |||||||||
683 | 38 | - | - | - | - | - | - | - | - |
Accrued liabilities | |||||||||
587 | 262 | - | - | - | - | - | - | - | - |
Deposits | |||||||||
- | - | 0 | 52 | 0 | 0 | - | - | - | - |
Accounts payable and accrued liabilities | |||||||||
- | - | 554 | 775 | 1,310 | -303 | 465 | 2,281 | 1,129 | 511 |
Deferred grant income | |||||||||
- | - | -70 | -1 | 71 | 0 | - | - | - | - |
Share subscriptions received | |||||||||
- | - | - | - | - | - | 60 | 0 | -100 | - |
Proceeds from the issuance of promissory notes | |||||||||
- | - | - | - | - | - | 250 | 581 | 750 | 1,415 |
Financing fees paid | |||||||||
- | - | - | - | - | 788 | 0 | 8 | 0 | 0 |
Net cash used in operating activities | |||||||||
-18,527 | -12,582 | -9,017 | -9,236 | -4,227 | - | -777 | -1,692 | -3,801 | -4,593 |
Acquisition of equipment | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 3 |
Net cash used in investing activities | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | -3 |
Net cash used in operating activities | |||||||||
- | - | - | - | - | -2,659 | - | - | - | - |
Acquisition of equipment | |||||||||
- | - | - | - | - | 3 | - | - | - | - |
Net cash used in investing activities | |||||||||
- | - | - | - | - | -3 | - | - | - | - |
Cash Flows provided by Financing Activities | |||||||||
Issuance of common shares | |||||||||
- | - | - | - | - | -368 | - | - | - | - |
Issuance of common shares | |||||||||
17,832 | 8,173 | 27,270 | 3,167 | 12,343 | - | 801 | 996 | 3,021 | 3,095 |
Deferred financing charges | |||||||||
50 | 101 | 0 | - | - | - | - | - | - | - |
Repayment of promissory notes | |||||||||
- | - | 0 | 34 | 88 | 0 | 0 | 0 | 0 | 0 |
Due to related parties | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Shareholder advances | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |
Net cash provided by financing activities | |||||||||
17,782 | 8,072 | 27,270 | 3,132 | 12,255 | - | 1,111 | 1,569 | 3,671 | 4,510 |
Proceeds from the issuance of convertible debentures | |||||||||
- | - | - | - | - | 10,000 | - | - | - | - |
Net cash provided by financing activity | |||||||||
- | - | - | - | - | 9,579 | - | - | - | - |
Decrease in cash and cash equivalents during the period | |||||||||
-745 | -4,509 | 18,253 | -6,104 | 8,028 | 6,917 | - | - | - | - |
Increase (decrease) in cash and cash equivalents during the period | |||||||||
- | - | - | - | - | - | 333 | -123 | -129 | -86 |